ArticleStrategies in trauma and limb reconstruction
Failure Modes in Ilizarov Limb Salvage: A Narrative Review of Technical, Biological, Patient-related and Systemic Determinants.
Article in Strategies in trauma and limb reconstruction. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim and background: The Ilizarov circular external fixator remains a cornerstone of limb salvage for infected non-unions, segmental bone defects, limb-length discrepancies and severe deformities. Despite consistently high union rates, treatment is prolonged and associated with a substantial burden of Paley-defined problems, obstacles and complications. This narrative review examines the technical, biological, patient-related and environmental determinants of failure and suboptimal outcomes following Ilizarov reconstruction, with particular emphasis on resource-limited settings. Materials and methods: A narrative synthesis of evidence from meta-analyses, large retrospective cohorts and representative case series was performed. Failure mechanisms were categorised into four domains: Technical factors, biological factors, patient-related factors and environmental/systemic influences. Evidence from low- and middle-income countries (LMICs) was specifically evaluated. Results: Reported bony union rates ranged from 85 to 95%; however, adverse event rates must be interpreted within Paley's framework. Most reported events represent expected and largely reversible treatment-related problems or obstacles inherent to prolonged external fixation rather than reconstructive failure. Aggregate rates of 90-406 Paley-defined events per 100 cases therefore reflect treatment burden rather than failure. Clinically significant complications, including persistent non-union, refracture and secondary amputation, comprised a smaller subset of adverse outcomes. Technical shortcomings contributed to malalignment regenerate deformity and docking-site non-union. Biological factors, particularly pin-site and deep infection, impaired regenerate formation and prolonged treatment. Patient noncompliance, psychological intolerance, malnutrition, smoking and metabolic disease increased failure risk, while socioeconomic constraints and limited rehabilitation resources exacerbated complications in resource-constrained settings. Conclusion: Successful Ilizarov reconstruction depends on technical precision, biological viability, patient engagement and environmental context. Multidisciplinary planning, realistic counselling and context-specific preventive strategies are essential to optimise outcomes in complex limb salvage reconstructions. Clinical significance: Recognition of modifiable failure pathways may help surgeons anticipate complications, refine treatment strategies and improve functional outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.